Bathi operasional EBITDA: 4D Molecular Corp (FDMT)
The prospects for 4D Molecular Therapeutics (FDMT) depend on confirming the efficacy of vectors in treating ocular pathologies. On GURU.Markets, the EBITDA trend reflects that the indicator has reached the level of 0.00. 4D Molecular Therapeutics (FDMT) is implementing bioengineered viruses for precise drug delivery, while competent management ensures the transparency of trials in cardiology and ophthalmology using advanced capsid platforms.
Ringkesan rincian data analitis 4D Molecular Therapeutics, Inc. (FDMT)
- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
- indikator nilai buku ekuitas:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas 4D Molecular Therapeutics|FDMT - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal 4DMT|FDMT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku 4D Molecular Therapeutics|FDMT - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan 4D Molecular Therapeutics|Indikator likuiditas cepet 4dmoleculartherapeutics.com
- data bathi bisnis lan rasio investasi:
FDMT - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep 4D Molecular Therapeutics|FDMT - Nilai perusahaan marang bathi resik|Pangali Forward P/E 4dmoleculartherapeutics.com|FDMT - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan 4D Molecular Therapeutics|FDMT - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) 4D Molecular Therapeutics|FDMT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan 4dmoleculartherapeutics.com|FDMT - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep 4D Molecular Therapeutics
- indikator dodolan lan pendapatan:
Ringkesan analitik perusahaan:4D Molecular Corp (FDMT)
This indicator measures net cash flow from operating activities, stripping out non-cash charges to reflect the business's actual ability to generate liquidity. The growth in EBITDA_Co monitoring for 4D Molecular Therapeutics (FDMT) confirms the effective monetization of its gene therapy platform through licensing agreements with big pharma, allowing the company to increase operating capital without incurring capital expenditures.
Analisis perusahaan pesaing
Tempus - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|QGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IONS - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi RGEN|Avidity Biosciences Inc (RNA) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi CRSP|Bathi operasional sadurunge ngurangi amortisasi GeneDx Corp (WGS)|Bathi operasional EBITDA RARE|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BEAM (beamtx.com)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|Bathi operasional EBITDA Twist Bioscience Inc TWST|10x Genomics Corp - Bathi operasional EBITDA|NTLA: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi Stoke Therapeutics STOK|Bathi operasional sadurunge ngurangi amortisasi biolifesolutions.com|WVE - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Maze Therapeutics, Inc. (MAZE)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi Sionna Pharma|Bathi operasional EBITDA Prime Medicine Bio (PRME)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi Taysha Gene Therapies|Bathi operasional EBITDA uniqure.com QURE|MGTX (MeiraGTx) - Bathi sadurunge bunga, pajak, lan amortisasi|RGNX: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi Solid Bio SLDB|Ocugen Pharma (OCGN) - Bathi operasional EBITDA|PACB (Pacific Biosciences) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BNTC|DSGN - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA Rocket Pharma (RCKT)|LXEO: Bathi sadurunge bunga, pajak, lan amortisasi|KRRO - Bathi operasional sadurunge ngurangi amortisasi|Editas Medicine, Inc. - Bathi operasional EBITDA|silence-therapeutics.com (SLN) - Bathi operasional sadurunge ngurangi amortisasi|PRQR - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Codexis (CDXS) - Bathi operasional EBITDA|SGMO: Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Nautilus Biotechnology Inc|Bathi operasional sadurunge ngurangi amortisasi MGX (Metagenomi, Inc.)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi DTIL (precisionbiosciences.com)|Pendapatan operasional sadurunge ngurangi amortisasi GBIO|Bathi operasional EBITDA Boundless Bio Inc. BOLD|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi Exicure Corp|IMNN - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi phiopharma.com|MBIO (Mustang Bio) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi RNAZ|Bathi operasional sadurunge ngurangi amortisasi Bionano (BNGO)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi Applied DNA|Bathi operasional EBITDA bluebird bio, Inc (BLUE)|IPA - Bathi operasional sadurunge amortisasi|omegatherapeutics.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Singular Genomics (OMIC) - Bathi operasional sadurunge amortisasi|RGLS - Bathi operasional EBITDA|SYRS: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi TBIO|TCON (TRACON Pharmaceuticals) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi UBX (unitybiotechnology.com)
